Answers are grounded in this paper and cite their sources.
A 62-year-old male on long-term adalimumab therapy presented with persistent, speckled hyperpigmentation precisely tracking the borders of his resolved psoriatic plaques, which remained unchanged despite 16 years of disease remission.
No takes yet. Share an insight, caveat, or question.
O’Kelly et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: